Abstract:Amyloid-beta (A{beta}) is a normal product of neuronal activity, and the two most common variants are 40 or 42 residues long. Of these, the 42 residue-version (A{beta}42) is normally less abundant but more prone to self-aggregate, and is thought to cause Alzheimer's disease (AD). Much knowledge about AD-pathogenesis comes from the study of rodents made to model aspects of the disease by expressing AD-relevant human transgenes, like human amyloid precursor protein (APP) containing mutations that drive up A{beta} production or increase the A{beta}42/40 ratio and thereby causes AD. Yet, when it comes to the normal expression of A{beta}42 in rodent brains, surprisingly little is known. Here we characterize the expression of A{beta}42 throughout the brain of normal, outbred Wistar rats, including animals from 3-18 months of age. We find that intracellular A{beta}42 (iA{beta}42) is present in neurons located throughout the brain at all ages of normal Wistar rats, but that the levels vary greatly between brain regions. In cortex, we observe the highest levels of iA{beta}42 in neurons that are part of layer II of the entorhinal cortex (EC), along with neurons in the hippocampus, closely followed by neurons in the somatosensory cortex. Among subcortical structures, we observe the highest levels iA{beta}42 in the locus coeruleus. In order to explore whether the striking presence of iA{beta}42 in rat EC also holds true in human subject free of neurological disease, we examined EC of six such cases ranging from ages 20-88 years. In all six cases, we find that iA{beta}42 is present in EC layer II-neurons. Our findings support two conclusions about iA{beta}42. First, iA{beta}42 is present in neurons of wild-type Wistar rats and is restricted to the same structures where iA{beta} accumulates, and A{beta}-plaques form, in a much used AD model based on Wistar rats (the McGill-R-Thy1-APP rat model). The difference between wild-type Wistar rats and these AD model rats, with respect to A{beta}42, is therefore a quantitative one rather that a qualitative one. This indicates that the McGill rat model in fact models the underlying wild-type neuronal population-specific vulnerability to A{beta}42-accumulation. Second, because the McGill rat model closely mimics the human AD-associated spatiotemporal sequence of amyloid plaque deposition, this model may offer a useful representation of the pre-plaque neuronal accumulation of iA{beta}42. Our findings in human cases are in line with prior findings, and substantiate the notion that neurons in layer II of EC are vulnerable to accumulation of iA{beta}42.

Aβ*56 is present in brain extracts enriched for extracellular proteins

Aβ∗56 is a stable oligomer that impairs memory function in mice

Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.

Some aspects of free field resolutions in 2-D CFT with application to the quantum Drinfeld-Sokolov reduction

Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains

Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects

Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease

Aβ42 and Aβ40: similarities and differences.

Proteomic Analysis Reveals Physiological Activities of Aβ Peptide for Alzheimer's Disease

Intracellular A beta and its Pathological Role in Alzheimer's Disease: Lessons from the Cellular to Animal Model

Truncated and Modified Aβ Species in Alzheimer's Disease

Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology

Nonfibrillar Diffuse Amyloid Deposition Due To A Gamma(42)-Secretase Site Mutation Points To An Essential Role For N-Truncated A Beta(42) In Alzheimer'S Disease

Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease

Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology